Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
08/20/2014 08/21/2014 08/22/2014 08/25/2014 08/26/2014 Date
7.75 7.7 7.7 7.78 7.9 Last
722 5100 1693 544 7177 Volume
+2.92% -0.65% 0.00% +1.04% +1.54% Change
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets. It operates through research and development of therapeutic agents segment. The company's products include ELND005 for the treatment of... 
Sector
Pharmaceuticals
Calendar
09/29Earnings Release
Surperformance© rating of Transition Therapeutics In
Trading Rating : Investor Rating :
More about the company
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Financials ( CAD)
Sales 2014 -
EBIT 2014 -21,7 M
Net income 2014 -19,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,83 M
EBIT 2015 -25,8 M
Net income 2015 -24,0 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 299x
Capitalization 249 M
More Financials
Latest news on TRANSITION THERAPEUTICS IN
08/06 TRANSITION THERAPEUTICS : Appoints Carl Damiani as Chief Operating Officer
06/10 TRANSITION THERAPEUTICS : Enters Into a Private Placement with Investors to Rece..
06/10 TRANSITION THERAPEUTICS : to Present at Jefferies 2014 Global Healthcare Confere..
06/06 IIROC Trade Resumption - Transition Therapeutics Inc.
06/06 IIROC Trade Halt - Transition Therapeutics Inc.
06/06 TRANSITION THERAPEUTICS : IIROC Trade Resumption - TTH
06/06 TRANSITION THERAPEUTICS : IIROC Trading Halt - TTH (all issues)
04/15 TRANSITION THERAPEUTICS : Announces No Material Change
03/26 TRANSITION THERAPEUTICS : to Present at the 34th Annual Cowen & Co. Healthcare C..
02/07 TRANSITION THERAPEUTICS INC : Transition Therapeutics to Hold Conference Call on..
2013 TRANSITION THERAPEUTICS INC : Transition Therapeutics Announces ELND005 Presenta..
2013DJTransition Buys Rights to TT-601 from Eli Lilly; Shares Up
More news
Comments 
Advertisement
Income Statement Evolution
Transition Therapeutics In : Income Statement Evolution
More Financials
EPS Revisions
Transition Therapeutics In : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF